These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2851765)
1. [Effects of pentoxifylline and propentofylline on the turnover of polyphosphoinositides of the erythrocyte membrane and on the metabolism of arachidonic acid in platelets]. Rossignol L; Plantavid M; Chap H; Douste-Blazy L Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1073-5. PubMed ID: 2851765 [TBL] [Abstract][Full Text] [Related]
2. Effects of two methylxanthines, pentoxifylline and propentofylline, on arachidonic acid metabolism in platelets stimulated by thrombin. Rossignol L; Plantavid M; Chap H; Douste-Blazy L Biochem Pharmacol; 1988 Sep; 37(17):3229-36. PubMed ID: 2840908 [TBL] [Abstract][Full Text] [Related]
3. [Permeability of the erythrocyte membrane to pentoxifylline and propentofylline. Research on their effects on some structural and functional properties of the membrane]. Chetrite G; Lebbar I; Cassoly R Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1066-72. PubMed ID: 3065698 [TBL] [Abstract][Full Text] [Related]
4. [Interaction between various alkylxanthines and the proteins of the erythrocyte skeleton]. Delaunay J; Pothier B; Baklouti F; Morlé L Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1076-80. PubMed ID: 3065699 [TBL] [Abstract][Full Text] [Related]
5. [The effect of pentoxifylline and propentofylline on the membrane fluidity of red blood cells in uncontrolled insulin-dependent (type 1) diabetic patients]. Roul C; Juhan-Vague I; Rahmani-Jourdheuil D; Mishal Z; Vague P Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1081-3. PubMed ID: 3065700 [TBL] [Abstract][Full Text] [Related]
6. Concerning the influence of pentoxifylline on the erythrocyte and platelet membranes. Stefanovich V Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S9. PubMed ID: 193056 [No Abstract] [Full Text] [Related]
7. [Methylxanthines and phosphorylation of the constituents of the membrane of the human red blood cell]. Biovin P; Lecomte MC; Galand C Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1042-6. PubMed ID: 2851763 [TBL] [Abstract][Full Text] [Related]
8. The effect of cyclic AMP-dependent protein kinase on the formation of polyphosphoinositides in erythrocyte membranes. Enyedi A; Sarkadi B; Faragó A; Szász I; Gárdos G Biomed Biochim Acta; 1983; 42(11-12):S130-1. PubMed ID: 6326763 [TBL] [Abstract][Full Text] [Related]
9. Interaction of pentoxifylline with human erythrocytes. I. Interaction of xanthine derivatives with human erythrocyte ghosts. Sato Y; Miura T; Suzuki Y Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):552-4. PubMed ID: 2337972 [TBL] [Abstract][Full Text] [Related]
10. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP. Weithmann KU Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055 [TBL] [Abstract][Full Text] [Related]
11. The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine. Fredholm BB; Lindström K Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):187-92. PubMed ID: 3012941 [TBL] [Abstract][Full Text] [Related]
13. On the influence of pentoxifylline on the permeability of rat erythrocytes for methyl-O-glucose. Stefanovich V; Porsche E; Müller E Arzneimittelforschung; 1979; 29(5):757-60. PubMed ID: 582974 [TBL] [Abstract][Full Text] [Related]
14. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets. Vickers JD J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627 [TBL] [Abstract][Full Text] [Related]
15. [Pentoxifylline and prostaglandins]. Poggesi L; Boddi M; Scarti L; Masotti G Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659 [No Abstract] [Full Text] [Related]
16. [In vitro effect of pentoxifylline on the metabolism of glycogen and the secretory process in the parotid and lacrimal extraorbital glands in rats]. Mauduit P; Herman G; Dreux C; Rossignol B Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1060-5. PubMed ID: 2851764 [TBL] [Abstract][Full Text] [Related]
17. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue. Matzky R; Darius H; Schrör K Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity. Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562 [TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP-dependent protein kinase stimulates the formation of polyphosphoinositides in the plasma membranes of different blood cells. Enyedi A; Faragó A; Sarkadi B; Szász I; Gárdos G FEBS Lett; 1983 Sep; 161(1):158-62. PubMed ID: 6309575 [TBL] [Abstract][Full Text] [Related]
20. [Comparative effects of pentoxifylline and of HWA 285 on mitochondrial maturation and biosynthesis of proteins in rats in the perinatal period]. Gautheron DC; Comte J; Meister R; Godinot C Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1056-9. PubMed ID: 3065697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]